Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
Megha Verma(Roskamp Institute), Daniel Paris(Roskamp Institute)
Cited by 35
Related Papers
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
|Journal of Neuroinflammation|2010|165
Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
|Frontiers in Cellular Neuroscience|2019|111